PICOPREP

This brand name is authorized in Austria, Brazil, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Japan, Lithuania, Netherlands, New Zealand, Romania, Singapore, Tunisia, Turkey, South Africa

Active ingredients

The drug PICOPREP contains a combination of these active pharmaceutical ingredients (APIs):

1 Sodium picosulfate
UNII LR57574HN8 - SODIUM PICOSULFATE

Sodium picosulfate is a locally acting laxative from the triarylmethane group, which after bacterial cleavage in the colon, has a dual-action with stimulation of the mucosa of both the large intestine and of the rectum.

Read about Sodium picosulfate
2 Magnesium oxide
UNII 3A3U0GI71G - MAGNESIUM OXIDE

Magnesium oxide (MgO), or magnesia, is an empirical formula of MgO and consists of a lattice of Mg2+ ions and O2− ions held together by ionic bonding.

Read about Magnesium oxide
3 Sodium citrate
UNII XF417D3PSL - ANHYDROUS CITRIC ACID

Sodium citrate has no relevant pharmacodynamic activity other than that caused by its alkalinity (e.g. its gastric acid neutralising capacity). Sodium citrate is a non-particulate antacid for use by mouth to prior to general anaesthesia for caesarean section.

Read about Sodium citrate

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
A06AB58 Sodium picosulfate, combinations A Alimentary tract and metabolism → A06 Laxatives → A06A Laxatives → A06AB Contact laxatives
Discover more medicines within A06AB58

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 521413110005505
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 1379-MEE-0915
Country: EE Ravimiamet Identifier(s): 1448524, 1500253, 1597495
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 72279
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 593795
Country: FR Base de données publique des médicaments Identifier(s): 66769608
Country: HK Department of Health Drug Office Identifier(s): 60968
Country: JP 医薬品医療機器総合機構 Identifier(s): 7990103A1029
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1051988, 1065443, 1068149
Country: NL Z-Index G-Standaard, PRK Identifier(s): 94994
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 21205, 9005
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W55638001, W55638002, W55638003
Country: SG Health Sciences Authority Identifier(s): 14303P
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 16143021
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8697621220638
Country: ZA Health Products Regulatory Authority Identifier(s): A38/11.5/0389

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.